• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼泊尔、马来西亚、黎巴嫩、缅甸和摩洛哥的医生对哮喘管理的知识、实践模式和态度。

Knowledge, practice pattern and attitude toward asthma management amongst physicians from Nepal, Malaysia, Lebanon, Myanmar and Morocco.

机构信息

Respiratory Medicine, Norvic International Hospital, Kathmandu, Nepal.

Medicine, MAHSA University, Selangor, Malaysia.

出版信息

J Asthma. 2021 Jul;58(7):979-989. doi: 10.1080/02770903.2020.1742351. Epub 2020 Apr 17.

DOI:10.1080/02770903.2020.1742351
PMID:32174204
Abstract

OBJECTIVE

This survey aimed to understand the physicians' practice pattern and challenges faced while treating their patients with asthma in five countries-Malaysia, Nepal, Myanmar, Morocco and Lebanon.

METHODS

Questionnaire-based data was gathered from internal medicine doctors (209), general practitioners (206), chest physicians (152) and pediatricians (58) from 232 locations from across the five countries.

RESULTS

Of the 816 physicians, 374 physicians encountered at least 5 asthma patients daily. Approximately, 38% physicians always used spirometry for diagnosis and only 12% physicians always recommended Peak flow meter (PFM) for home-monitoring. Salmeterol/fluticasone (71%) followed by formoterol/budesonide (38%) were the most preferred ICS/long-acting beta-agonists (LABA); Salbutamol (78%) was the most preferred reliever medication. 60% physicians said >40% of their patients were apprehensive to use inhalers. 72% physicians preferred a pressurized metered-dose inhaler (pMDI) to a dry powder inhaler (DPI) with only a third of them using a spacer with the pMDI. 71% physicians believed that using similar device for controller and reliever can be beneficial to patients. Skipping medicines in absence of symptoms (64%), incorrect inhaler technique (48%) and high cost of medication (49%) were considered as major reasons for non-adherence by most physicians. Incorrect inhaler technique (66%) and nonadherence (59%) were considered the most common causes of poor asthma control.

CONCLUSIONS

There are opportunities to improve the use of diagnostic and monitoring tools for asthma. Non-adherence, incorrect inhaler technique and cost remain a challenge to achieve good asthma control. Asthma education, including correct demonstration of inhaler, can potentially help to improve inhaler adherence.

摘要

目的

本调查旨在了解马来西亚、尼泊尔、缅甸、摩洛哥和黎巴嫩这五个国家的内科医生、全科医生、胸科医生和儿科医生在治疗哮喘患者时的实践模式和面临的挑战。

方法

从这五个国家的 232 个地点收集了 816 名内科医生(209 名)、全科医生(206 名)、胸科医生(152 名)和儿科医生(58 名)的基于问卷的数据。

结果

在 816 名医生中,有 374 名医生每天至少遇到 5 名哮喘患者。大约 38%的医生总是使用肺活量计进行诊断,只有 12%的医生总是建议使用峰流速仪(PFM)进行家庭监测。沙美特罗/氟替卡松(71%)其次是福莫特罗/布地奈德(38%)是最受欢迎的吸入性皮质类固醇/长效β激动剂(ICS/LABA);沙丁胺醇(78%)是最受欢迎的缓解药物。60%的医生表示,他们的患者中有超过 40%对使用吸入器感到担忧。72%的医生更喜欢压力定量吸入器(pMDI)而不是干粉吸入器(DPI),只有三分之一的医生在使用 pMDI 时使用了吸入器。71%的医生认为为患者使用类似的设备用于控制器和缓解器可能是有益的。大多数医生认为,在没有症状的情况下停药(64%)、吸入器技术不正确(48%)和药物费用高(49%)是导致不遵医嘱的主要原因。不正确的吸入器技术(66%)和不遵医嘱(59%)被认为是哮喘控制不佳的最常见原因。

结论

有机会改善哮喘诊断和监测工具的使用。不遵医嘱、吸入器技术不正确和费用仍然是实现良好哮喘控制的挑战。哮喘教育,包括正确演示吸入器,有可能有助于提高吸入器的依从性。

相似文献

1
Knowledge, practice pattern and attitude toward asthma management amongst physicians from Nepal, Malaysia, Lebanon, Myanmar and Morocco.尼泊尔、马来西亚、黎巴嫩、缅甸和摩洛哥的医生对哮喘管理的知识、实践模式和态度。
J Asthma. 2021 Jul;58(7):979-989. doi: 10.1080/02770903.2020.1742351. Epub 2020 Apr 17.
2
Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.不同吸入性糖皮质激素及其与长效β2受体激动剂联合使用治疗12岁及以上成人和儿童慢性哮喘比较效果的系统评价与经济学分析
Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. doi: 10.3310/hta12190.
3
An innovative corticosteroid/long-acting β-agonist breath-triggered inhaler: facilitating lung delivery of fluticasone propionate/formoterol fumarate for the treatment of asthma.一种创新的皮质类固醇/长效β-激动剂呼气触发式吸入器:促进丙酸氟替卡松/富马酸福莫特罗在肺部的递送,用于哮喘治疗。
Expert Opin Drug Deliv. 2019 Dec;16(12):1367-1380. doi: 10.1080/17425247.2019.1689957. Epub 2019 Nov 28.
4
APPaRENT 3: Asthma Patients' and Physicians' Perspectives on the Burden and Management of Asthma in Seven Countries.APPaRENT 3:七个国家哮喘患者和医生对哮喘负担和管理的看法。
Adv Ther. 2024 Aug;41(8):3089-3118. doi: 10.1007/s12325-024-02900-2. Epub 2024 Jun 14.
5
Comparing the efficacy and safety of formoterol/budesonide pMDI versus its mono-components and other LABA/ICS in patients with asthma.比较福莫特罗/布地奈德 pMDI 及其单一组分与其他 LABA/ICS 在哮喘患者中的疗效和安全性。
Respir Med. 2020 Aug-Sep;170:106055. doi: 10.1016/j.rmed.2020.106055. Epub 2020 Jun 1.
6
Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.用信必可都保(布地奈德/福莫特罗吸入气雾剂)治疗持续性哮喘:一种吸入性糖皮质激素和长效β2肾上腺素能激动剂在一个压力定量吸入器中。
J Asthma. 2010 May;47(4):447-59. doi: 10.3109/02770901003725684.
7
Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.吸入性皮质类固醇或长效β-激动剂单独或固定剂量联合治疗哮喘:氟替卡松/布地奈德和福莫特罗/沙美特罗的系统评价。
Clin Ther. 2009 Dec;31(12):2779-803. doi: 10.1016/j.clinthera.2009.12.021.
8
Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.哮喘患者使用可调节剂量和固定剂量的布地奈德/福莫特罗压力定量吸入器与固定剂量的丙酸氟替卡松/沙美特罗干粉吸入器治疗期间患者报告结局的比较。
J Asthma. 2010 Mar;47(2):217-23. doi: 10.3109/02770900903497154.
9
Preference of diagnostic tools, medications, and devices for asthma management: A survey of doctors in Algeria.哮喘管理中诊断工具、药物和设备的偏好:阿尔及利亚医生的一项调查。
Perspect Clin Res. 2019 Apr-Jun;10(2):67-72. doi: 10.4103/picr.PICR_63_18.
10
Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation.改变吸入器设备是否会影响现实生活中的哮喘结局?临床和经济评估。
J Allergy Clin Immunol Pract. 2019 Mar;7(3):934-942. doi: 10.1016/j.jaip.2018.09.027. Epub 2018 Oct 5.

引用本文的文献

1
Burden and unmet needs in asthma care in the Asia-Pacific region.亚太地区哮喘护理的负担与未满足的需求。
Public Health Chall. 2022 Aug 29;1(3):e15. doi: 10.1002/puh2.15. eCollection 2022 Sep.
2
How Do Pediatricians Diagnose Asthma in Tertiary Care Hospitals?三级医疗医院的儿科医生如何诊断哮喘?
Cureus. 2022 Sep 30;14(9):e29768. doi: 10.7759/cureus.29768. eCollection 2022 Sep.
3
Physicians' Knowledge and Practices Regarding Asthma: A Cross-Sectional Study in Saudi Arabia.医生对哮喘的认知与实践:沙特阿拉伯的一项横断面研究。
Int J Gen Med. 2022 Aug 19;15:6671-6680. doi: 10.2147/IJGM.S369306. eCollection 2022.